Team:BGU Israel/HPOverview
From 2013.igem.org
Neta.weiss (Talk | contribs) |
Neta.weiss (Talk | contribs) |
||
Line 43: | Line 43: | ||
<div class="topics-text_hp"> | <div class="topics-text_hp"> | ||
<h6>Survey</h6> | <h6>Survey</h6> | ||
- | + | Understanding Public Opinion | |
</div> | </div> | ||
</a> | </a> | ||
Line 52: | Line 52: | ||
<div class="topics-text_hp"> | <div class="topics-text_hp"> | ||
<h6>Outreach</h6> | <h6>Outreach</h6> | ||
- | + | Starting a Discussion | |
</div> | </div> | ||
</a> | </a> | ||
Line 61: | Line 61: | ||
<div class="topics-text_hp"> | <div class="topics-text_hp"> | ||
<h6>Continuity</h6> | <h6>Continuity</h6> | ||
- | + | Building a Foundation | |
</div> | </div> | ||
</a> | </a> |
Revision as of 21:21, 28 October 2013
In the earliest stages of brainstorming about our project, we asked ourselves:
What is standing in the way of making synthetic biology projects reality?
There are hundreds of biologically engineered systems that have been developed, but the move from the lab into the real world has been slow. What is holding up progress? We concluded that there are two main issues that are stopping this field from realizing its full potential:
1) There are too many
References:[1]DAVID BEN-GURION, “Why I Retired to the Desert,” The New York Times Magazine, March 28, 1954, p. 47.